Table: Torii Pharmaceutical -2018 parent results
Feb 6 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2018 Dec 31, 2017 Dec 31, 2019 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 62.55 64.14 38.00
(-2.5 pct) (+6.5 pct) (-39.2 pct)
Operating 4.95 6.28 loss 3.20
(-21.2 pct) (+64.5 pct)
Recurring 5.08 6.40 loss 3.10
(-20.7 pct) (+60.1 pct)
Net 1.16 4.72 22.50
(-75.3 pct) (+66.1 pct)
EPS 41.51 yen 168.22 yen 801.82 yen
EPS Diluted 168.22 yen
Ann Div 48.00 yen 48.00 yen 48.00 yen
-Q2 Div 24.00 yen 24.00 yen 24.00 yen
-Q4 Div 24.00 yen 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)